Goldman Sachs lowered the firm’s price target on Veeva (VEEV) to $190 from $215 and keeps a Sell rating on the shares. Veeva’s Q4 results beat Street estimates modestly, driven largely by Professional Services, while FY27 subscription revenue guidance came in roughly in line with consensus, with services slightly higher, the analyst tells investors in a research note. Key factors for future growth include the ramp of specific product cycles, the final composition of CRM commitments, and adoption of AI in R&D workflows, though questions around CRM competition and Veeva’s role in the broader AI stack may constrain near-term share performance, Goldman says.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Veeva price target raised to $215 from $205 at Morgan Stanley
- Veeva price target raised to $220 from $200 at UBS
- Veeva price target raised to $245 from $212 at Stifel
- Veeva price target raised to $235 from $200 at Canaccord
- Strong Near-Term Execution but Uncertain Long-Term Growth Drivers Justify Hold on Veeva
